Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5626_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •List of Contributors
- •Preface
- •1.2.4 Ancient Egypt
- •1.2.5 The Greeks
- •1.2.6 Arabic and Islamic Region
- •1.3 Development of Pharmacognosy in the Modern Era
- •1.4 The Relevance of Pharmacognosy in Pharmacological Research on Herbal Medicinal Products
- •1.5 Taxonomy and Botanical Authenticity
- •1.5.1 Plant Identification
- •1.5.2 Plant Nomenclature
- •1.5.3 Plant Classification
- •1.6 Phytochemistry – An Expanded Role in Traditional Medicine (History and Progress in Drug Discovery)
- •1.7 Recent Progress in Pharmacognosy and Phytochemistry
- •1.7.1 Bioactivity-guided Fractionation
- •1.7.2 Identification of Bioactive Compounds from Adulterants
- •1. Historical Overview of Pharmacognosy and Phytochemistry
- •1.1 Introduction to Pharmacognosy
- •1.2 Historical Development of Pharmacognosy
- •1.2.1 Mesopotamia Region
- •1.2.2 China
- •1.2.3 India
- •1.7.3 Omics Approach
- •1.7.4 Phytopharmacology and Mechanistic Studies
- •1.7.5 Multitargeted Approaches
- •1.7.6 Bioavailability and Drug Delivery Systems
- •1.7.7 Computational Approaches
- •1.7.8 Standardization and Quality Control
- •1.7.9 Nutraceuticals and Functional Foods
- •1.7.10 Sustainability and Conservation
- •1.7.11 Microbial Interactions and Co-cultivation
- •1.7.12 Biotechnological Approaches
- •1.7.13 Green Extraction Technology
- •1.7.14 Big Data and Artificial Intelligence
- •1.8 Conclusion
- •References
- •2. Classification of Crude Drugs of Natural Origin
- •2.1 Introduction
- •2.1.1 Definition of Crude Drugs
- •2.1.2 Importance of Classification of Crude Drugs
- •2.1.3 Early Attempts at Classification of Crude Drugs
- •2.2 Botanical Classification
- •2.2.1 Division Based on Plant Families
- •2.2.2 Importance of Taxonomy in Identifying and Categorizing Crude Drugs
- •2.2.3 Examples of Common Plant Families and Their Medicinal Representatives
- •2.3 Morphological Classification
- •2.3.1 Division Based on Plant Parts Used for Medicinal Purposes
- •2.3.1.1 Leaves
- •2.3.1.2 Roots
- •2.3.1.3 Stems
- •2.3.1.4 Bark
- •2.3.1.5 Flowers
- •2.3.1.6 Fruits
- •2.3.1.7 Seeds
- •2.3.2 Examination of Macroscopic and Microscopic Characteristics for Identification
- •2.3.3 Importance of Organoleptic Properties in Morphological Classification
- •2.4 Chemical Classification
- •2.4.1 Division Based on the Primary Active Chemical Constituents and Major Classes
- •2.4.1.1 Alkaloids
- •2.4.1.2 Glycosides
- •2.4.1.3 Volatile oils/terpenoids
- •2.4.1.4 Phenolic compounds
- •2.5 Pharmacological Classification
- •2.5.2 Relationship Between Pharmacological Activities and Chemical Constituents
- •2.6 Taxonomical Classification
- •2.6.1 Plant-Based Crude Drugs
- •2.6.2 Animal-Based Crude Drugs
- •2.6.3 Mineral-Based Crude Drugs
- •2.7 Chemotaxonomical Classification
- •2.7.1 Understanding of Chemotaxonomy
- •2.7.2 Chemotaxonomical Classes of Crude Drugs
- •2.7.2.1 Alkaloids
- •2.7.2.2 Flavonoids
- •2.7.2.3 Terpenoids
- •2.7.2.4 Phenolic Compounds
- •2.7.2.5 Glucosinolates
- •2.8 Geographical Classification
- •2.8.1 Division Based on the Geographic Origin of Crude Drugs
- •2.8.1.1 Tropical Drugs
- •2.8.1.2 Temperate Drugs
- •2.8.1.3 Arctic and Alpine Drugs
- •2.8.1.4 African Drugs
- •2.8.2 Influence of Climate, Soil, and Environmental Factors on Medicinal Properties
- •2.8.3 Examples of Region-specific Crude Drugs and Their Uses
- •2.9 Traditional and Cultural Classification
- •2.9.1 Division Based on Traditional Medicine Systems
- •2.9.2 Preservation of Traditional Knowledge in Classifying Crude Drugs
- •2.10 Modern Analytical Techniques in Classification
- •2.10.1 Use of Advanced Analytical Methods
- •2.10.1.1 Infrared Spectroscopy
- •2.10.1.2 Atomic Absorption Spectrometry
- •2.10.1.3 Inductively Coupled Plasma Mass Spectrometry
- •2.10.1.4 Chromatography Techniques
- •2.11.1.3 Taxonomic Bias and Expertise
- •2.11.2 Ethical Considerations in Classifying Endangered Plant Species
- •2.11.2.1 Data Accessibility and Accuracy
- •2.11.2.2 Taxonomic Uncertainties
- •2.11.2.3 Inadequate Resources for Research
- •2.11.2.4 Conservation Prioritization
- •2.11.2.5 Ex Situ Conservation and Access to Genetic Resources
- •2.11.2.6 Cultural and Traditional Knowledge
- •2.12 Future Perspectives
- •2.12.1 Integration of Traditional and Modern Classification Approaches for Crude Drugs
- •2.12.1.1 Incorporating Traditional Classification Systems
- •2.12.1.2 Analyzing Chemical Composition and Pharmacology
- •2.12.1.3 Bridging the Gap
- •2.12.1.4 Safety and Regulation
- •2.12.1.5 Research and Innovation
- •2.12.1.6 Holistic Patient Care
- •2.12.2 Role of Artificial Intelligence and Machine Learning
- •2.12.2.1 Data Analysis and Pattern Recognition
- •2.12.2.2 Predictive Modeling
- •2.12.2.3 Drug–Drug Interactions and Safety
- •2.12.2.4 Quality Control
- •2.12.2.5 Data Integration and Literature Mining
- •2.12.3 Emerging Trends and Innovations in the Field
- •2.13 Conclusion
- •2.13.1 Recapitulation of the Significance of Classification in Understanding Crude drugs
- •2.13.2 Importance of Accurate Classification of Crude Drugs for Safe and Effective Use in Medicine
- •2.13.3 Call to Further Research and Collaboration in Advancing Crude Drug Classification
- •References
- •2.10.2 Role of DNA Barcoding in Accurate Identification and Classification
- •2.10.3 Advantages and Challenges of Modern Techniques
- •2.11 Challenges in Classification
- •2.11.1 Overlapping Chemical Constituents in Different Classes
- •2.11.1.1 Polyploidy and Hybridization
- •2.11.1.2 Rapid Evolution and Speciation
- •3. Folk Medicine as a Source of Therapeutically Important Drugs: Evidence from Ethnobotanical Investigations
- •3.1 Introduction
- •3.1.1 Market Potential of Herbal Medicines
- •3.1.2 Early Records of Folk Medicine
- •3.1.3 Origin and Definition of Ethnobotany
- •3.1.4 History of Ethnobotany
- •3.1.5 Subdisciplines of Ethnobotany
- •3.2 Traditional Medical Systems
- •3.2.1 African Traditional Medicine
- •3.2.2 American Traditional Medicine (North, Central, and South)
- •3.2.3 Australian and Southeast Asian Medicine
- •3.2.4 Ayurvedic Medicine (Indian Traditional Medicine)
- •3.2.5 Chinese Traditional Medicine
- •3.2.6 European Medicine
- •3.2.7 Classical Arabic, North African Traditional Medicine
- •3.3 Importance of Ethnobotanical Research in Drug Discovery
- •3.4 Biological Activity of Medicinal Plants
- •3.4.1 Anticancer Activity
- •3.4.2 Antidiabetic Activity
- •3.4.3 Gastrointestinal Disorders
- •3.4.4 Respiratory Disorders
- •3.4.5 Antiviral Activity
- •3.4.6 Anti-inflammatory Activity
- •Acknowledgments
- •References
- •4. Complementary and Alternative Medicinal Systems
- •4.1 Introduction
- •4.2 Ayurveda System
- •4.2.1 History of Ayurveda
- •4.2.2 Principles of Ayurveda
- •4.2.2.1 Panchamahabhuta Siddhanta
- •4.2.2.2 Tridosha
- •4.2.2.3 Dhatus
- •4.2.2.4 Upadhatus
- •4.2.2.5 Malas
- •4.2.2.6 Srotas
- •4.2.2.7 Agni
- •4.2.2.8 Prakriti
- •4.2.3 Ayurvedic Methods of Diagnosis
- •4.2.3.1 Ayurvedic Treatment
- •4.2.4 Ayurvedic Formulations
- •4.3 Unani System
- •4.3.1 History of Unani System
- •4.3.2 Principles of Unani
- •4.3.3 Methods of Diagnosis
- •4.3.4 Treatment
- •4.3.4.1 Ilaj-Bil-Tadbeer (Regimental Therapy)
- •4.3.4.2 Ilaj-Bil-Dawa (Pharmacotherapy)
- •4.3.4.3 Ilaj-Bil-Yad (Surgical therapy)
- •4.3.5 Unani Formulations
- •4.4 Siddha System
- •4.4.1 History
- •4.4.2 Principles of Siddha
- •4.4.2.1 Five Elements
- •4.4.2.2 Seven Physical Constituents
- •4.4.2.3 Humours (Uyir Thathukkal)
- •4.4.2.4 Vaatham (Vali)
- •4.4.2.5 Pitham (Azhal)
- •4.4.2.6 Kapham (Aiyaam)
- •4.4.3 Methods of Diagnosis
- •4.4.3.1 Physical Examination of Urine
- •4.4.3.2 Pulse
- •4.4.3.3 Wrist Circumferential Sign
- •4.4.4 Treatment
- •4.4.5 Siddha Formulations
- •4.5 Homeopathy System
- •4.5.1 History
- •4.5.2 Principles of Homeopathy
- •4.5.3 Methods of Diagnosis and Treatment
- •4.6 Conclusion
- •References
- •5. Cultivation, Collection, and Preparation of Plant Drugs
- •5.1 History
- •5.2 Cultivation
- •5.2.1 Need of Medicinal Plants Cultivation
- •5.2.2 Limitation of Cultivation
- •5.2.3 Types of Cultivations
- •5.2.3.1 Sexual Propagation
- •5.2.3.2 Asexual Propagation
- •5.3 Factors Affecting Cultivation
- •5.3.1 Soil
- •5.3.2 Altitude, Temperature, and Humidity
- •5.3.3 Rainfall and Irrigation
- •5.3.4 Fertilizers and Manures in Plant Nutrition
- •5.3.5 Pests and Pest Control
- •5.3.6 Pest Control
- •5.3.6.1 Natural Method
- •5.3.6.4 Chemical Methods
- •5.4 Good Agricultural Practice
- •5.4.1 Objectives
- •5.4.2 Identification/Authentication of Cultivated Medicinal Plants
- •5.4.2.1 Medicinal Plants Selection
- •5.4.2.2 Botanical Identity
- •5.4.2.3 Specimens
- •5.4.3 Seeds and Other Propagation Materials
- •5.4.4 Site Selection
- •5.4.5 Soil
- •5.4.6 Fertilizers and Manures
- •5.4.7 Climate
- •5.4.8 Irrigation and Drainage
- •5.4.9 Plant Maintenance and Protection
- •5.4.10 Harvest
- •5.5 Good Collection Practices for Medicinal Plants
- •5.5.1 Collection Permissions
- •5.5.2 Technical Planning
- •5.5.3 Social and Ecological Impact
- •5.5.4 Selection of Medicinal Plants for Collection
- •5.6 Processing of Medicinal Plants
- •5.6.1 Primary Processing
- •5.6.2 Secondary Processing
- •5.6.2.1 Cutting/sectioning
- •5.6.2.2 Aging/sweating
- •5.6.2.3 Baking/roasting
- •5.6.2.4 Boiling/steaming
- •5.6.2.5 Stir-frying
- •5.7 Storage and Packaging
- •5.8 Sample Record for Cultivated Medicinal Plants
- •5.9 Voluntary Certification Scheme for Medicinal Plant Produce in Indian Scenario
- •5.9.1 Certification Process: For individual farmer/collector
- •References
- •6. Adulteration and Evaluation of Crude Drugs of Natural Origin
- •6.1 Introduction
- •6.2 Adulteration of Herbal Drugs
- •6.2.1 Poisonous or Deleterious Substances
- •6.2.1.1 Types of Poisonous or Deleterious Adulterants
- •6.2.2 Filth and Foreign Matter of Adulteration
- •6.2.2.1 Types and Examples
- •6.2.3 Microbiological Contamination
- •6.2.3.1 Examples of Microbiological Contamination
- •6.3 Types of Adulteration
- •6.3.1 Intentional/Deliberate Adulteration
- •6.3.2 Unknown or Incidental Adulteration
- •6.3.3 Metallic Contamination
- •6.3.4 Adulteration in Synthetic and Artificial Substances
- •6.4 Adulteration in Medicinal Plants
- •6.4.1 Reasons for Adulteration
- •6.4.2 Adulteration Caused Because of the Similar Morphology
- •6.4.3 Adulteration Caused Because of Confusion in Vernacular Names
- •6.4.4 Insufficient Basic Understanding of the Real Plant Source
- •6.5 Methods of Detection of Adulterants and Evaluation of Medicinal Herbs
- •6.5.1 Taxonomic Deciding Adulteration of Medicinal Plants
- •6.5.2 Morphological Analysis
- •6.5.3 Microscopic Analysis
- •6.5.4 Organoleptic Analysis
- •6.5.5 Qualitative and Quantitative of Phytochemical for Detection of Contaminants
- •6.5.6 Establishment of Fingerprint Profiles
- •6.5.7 Multiple Marker-based Fingerprint Profiles for Detection of Adulterants
- •6.6 Analytical Techniques in the Detection and Evaluation of Adulterants
- •6.6.1 Microscopy
- •6.6.2 Chromatographic Techniques
- •6.6.2.1 Thin-layer Chromatography
- •6.6.2.2 High-performance Liquid Chromatography
- •6.6.2.3 Gas Chromatography
- •6.6.3 Hyphenated Techniques
- •6.6.3.1 Gas Chromatography-mass Spectrometry
- •6.6.3.2 Liquid Chromatography-mass Spectrometry
- •6.6.4 Spectroscopic Methods
- •6.6.4.1 Nuclear Magnetic Resonance Spectroscopy
- •6.6.4.2 Mass Spectrometry
- •6.7 Challenges in Detection of Adulterants
- •6.8 Conclusion and Future Perspectives
- •References
- •7. Methods of Extraction
- •7.1 Introduction
- •7.2 Ideal Properties of Solvent
- •7.3 Solvents for Extraction
- •7.4 Factor Affecting Extraction Methods
- •7.5 Mechanism of Extraction
- •7.6 Methods of Extraction
- •7.6.1 Decoction
- •7.6.2 Maceration
- •7.6.2.1 Modified Macerations
- •7.6.3 Percolation
- •7.6.3.1 Imbibition
- •7.6.3.2 Maceration
- •7.6.3.3 Percolation
- •7.6.4 Soxhlation (Hot Continuous Percolation)
- •7.6.5 Extraction of Essential Oil Techniques
- •7.6.5.1 Distillation
- •7.6.5.1.1 Disadvantages of Hydro Distillation
- •7.6.5.1.2 Hydro Steam Distillation
- •7.6.5.1.3 Advantages of Hydro and Steam Distillation over Hydro Distillation
- •7.6.5.1.4 Disadvantages of Hydro and Steam Distillation over Water Distillation
- •7.6.5.1.5 Direct Steam Distillation
- •7.6.5.2 Expression
- •7.6.5.3 Ecuelle
- •7.6.5.4 Enfleurage
- •7.6.5.5 Hot Maceration Process/Digestion
- •7.6.5.6 Pneumatic Method
- •7.6.6 Phytonics
- •7.6.7 Pressurized Liquid Extraction/Accelerated Solvent Extraction
- •7.6.8 Pulsed Electric Field Extraction
- •7.6.9 Ultrasound-assisted Extraction
- •7.6.10 Microwave-assisted Extraction
- •7.6.11 Supercritical Fluid Extraction
- •References
- •8. Qualitative and Quantitative Methods of Phytochemical Analysis
- •8.1 Introduction
- •8.2 Phytochemical Screening Through Chemical Test
- •8.2.1 Alkaloids
- •8.2.2 Glycosides
- •8.2.3 Flavanoids
- •8.2.4 Tannins
- •8.2.5 Saponins
- •8.2.6 Terpenoids
- •8.2.7 Carbohydrates
- •8.3 Quantitative Methods of Phytochemical Analysis
- •8.3.1 Determination of total phenolic content
- •8.3.1.1 Folin-Ciocalteu Method
- •8.3.2 Determination of Total Flavonoid Content
- •8.3.2.1 Determination of Tannins
- •8.3.2.2 Estimation of Total Tannin Content
- •8.3.2.3 Determination of Total Alkaloid
- •8.3.2.4 Determination of Carbohydrates
- •8.3.2.5 Determination of Protein
- •8.3.3 Analytical Parameters for Fixed Oils and Waxes
- •8.4 Analytical Techniques In Phytochemical Analysis
- •8.5 Conclusion
- •References
- •9. Modern Analytical Techniques for Quality Control and Chemical Identification of Phytochemicals
- •9.1 Introduction
- •9.1.1 Background and Significance of Phytochemicals
- •9.1.2 Importance of Quality Control and Chemical Identification
- •9.1.3 Overview of Modern Analytical Techniques
- •9.2 Chromatographic Techniques
- •9.2.1 High-performance Liquid Chromatography
- •9.2.2 Gas Chromatography
- •9.2.3 Thin-layer Chromatography and High-performance Thin-layer Chromatography
- •9.3 Spectroscopic Techniques
- •9.3.1 Ultraviolet-visible Spectroscopy
- •9.3.2 Fourier Transform Infrared Spectroscopy
- •9.3.3 Nuclear Magnetic Resonance
- •9.4 Mass Spectrometry
- •9.4.1 Structural Elucidation of Phytochemicals by Mass Spectrometry
- •9.4.2 Quantitative Analysis and Quality Control Measures
- •9.4.2.1 Quantitative Analysis for Phytochemicals
- •9.4.2.1.1 External Calibration
- •9.4.2.1.2 Internal Standardization
- •9.4.2.1.3 Isotope Dilution Analysis
- •9.4.2.2 Quality Control Measures for Phytochemicals
- •9.5 Hyphenated Techniques
- •9.5.1 LC-MS and GC-MS Applications in Phytochemical Analysis
- •9.5.2 LC-NMR-MS for Comprehensive Structural Elucidation
- •9.6 Chemometric Tools and Data Analysis
- •9.6.1 Multivariate Analysis Techniques and Quality Control and Pattern Recognition Methods
- •9.7 Advanced Technologies
- •9.7.1 Metabolomics in Phytochemical Analysis and Molecular Imaging Techniques
- •9.8 Challenges and Future Perspectives
- •9.8.1 Current Challenges in Phytochemical Analysis
- •9.8.2 Future Directions and Emerging Technologies
- •9.9 Conclusion
- •References
- •10. Classification and Therapeutic Applications of Plant Secondary Metabolites
- •10.1 Introduction
- •10.1.1 Types of PSMs
- •10.1.2 Functions of PSMs
- •10.2 Classification of PSMs
- •10.2.1 Alkaloids
- •10.2.2 Terpenoids
- •10.2.3 Phenolic Compounds
- •10.2.4 Glycosides
- •10.2.5 Tannins
- •10.2.6 Saponins
- •10.3 Biosynthetic Pathways
- •10.4 Environmental Factors Affecting PSMs
- •10.5 Genetic Factors Affecting PSMs
- •10.6 Role of Enzymes in Plant Secondary Metabolite Production
- •10.7 PSMs Therapeutic Applications
- •10.7.1 Antimicrobial Properties
- •10.7.2 Anticancer Potential
- •10.7.3 Anti-inflammatory and Immunomodulatory Effects
- •10.7.4 Neuroprotective and Cognitive Benefits
- •10.7.5 Cardiovascular Health Benefits
- •10.7.6 Antioxidant and Antiaging Effects
- •10.8 Safety and Toxicity Considerations
- •10.8.1 Plant Toxicity
- •10.8.2 Potential Health Risks
- •10.9 Standardization of Herbal Medicine Using PSMs
- •10.9.1 Methods Used for Standardization of Herbal Medicines
- •10.9.2 Obstacles in Standardizing Herbal Medicines Related to PSMs
- •10.9.3 Variations in PSMs that Affect the Standardization Process
- •10.10 Conclusion
- •References
- •11. Isolation, Fractionation, and Purification of Natural Products
- •11.1 Introduction
- •11.2 Extraction
- •11.2.1 Consideration for the Extraction
- •11.2.2 Factors Affecting Extraction
- •11.2.3 Selection of Appropriate Solvent for Extraction
- •11.3 Extraction Methods/Technique
- •11.3.1 Maceration
- •11.3.2 Percolation
- •11.3.3 Soxhlet Extraction
- •11.3.4 Supercritical Fluid Extraction
- •11.3.5 Microwave-assisted Extraction
- •11.3.6 Pressurized Liquid Extraction
- •11.3.7 Ultrasound-assisted Extraction
- •11.3.8 Extraction with Ionic liquids
- •11.3.9 Accelerated (Pressurized) Solvent Extraction
- •11.4 Fractionation Techniques
- •11.4.1 Liquid–Liquid Fractionation
- •11.4.2 Chromatographic Techniques
- •11.4.2.1 Column Chromatography
- •11.4.2.2 Thin Layer Chromatography
- •11.4.2.3 High-performance Liquid Chromatography
- •11.4.2.4 Vacuum Liquid Chromatography
- •11.4.3 With Advances in Fractionation Techniques to Isolate and Purify Natural Products (e.g. counter-current chromatography)
- •11.5 Purification
- •11.5.1 Importance and Goals of Purification
- •11.5.2 Crystallization, Distillation, and Sublimation
- •11.5.2.1 Crystallization
- •11.5.2.2 Distillation
- •11.5.2.3 Sublimation
- •11.5.3 Advanced Purification Techniques
- •11.5.3.1 Flash Chromatography
- •11.5.3.2 Preparative HPLC
- •References
- •12. Pharmacological Screening of Drugs from Natural Sources
- •12.1 Introduction
- •12.2 Pharmacological Approaches
- •12.2.1 Discovery of Biologically Active Compounds
- •12.2.2 Pharmacological Screening Methods
- •12.2.2.1 In vivo Models
- •12.2.2.1.1 Screening Models for Cardiovascular System Diseases
- •12.2.2.1.2 Screening Models for Nervous System Diseases
- •12.2.2.1.3 Screening Models for Respiratory System Diseases
- •12.2.2.1.4 Screening Models for Urinary System Diseases
- •12.2.2.1.5 Screening Models for Musculoskeletal Diseases
- •12.2.2.1.6 Screening Models for Digestive System Diseases
- •12.2.2.1.7 Screening Models for Metabolic Diseases
- •12.2.2.1.8 Screening Models for Cancer
- •12.2.2.1.9 Screening Models for Immunomodulatory Diseases
- •12.2.2.1.10 Screening Models for Ophthalmic Diseases
- •12.2.2.1.11 Screening Models for Anti-inflammatory Activity
- •12.2.2.1.13 Screening Models for Antipyretic Activity
- •12.2.2.1.14 Screening Models for Dermal Diseases
- •12.2.2.2 In Vitro Models
- •12.2.2.2.1 Isolated Organs
- •12.2.2.2.2 Culture Methods
- •12.2.2.2.3 Enzyme Inhibition and Receptor Binding Assay
- •12.3 Conclusion
- •References
- •13. Biosynthetic Pathways of Phytopharmaceuticals
- •13.1 Introduction
- •13.1.1 Biosynthetic Pathway
- •13.1.2 History
- •13.1.3 Gross Idea
- •13.1.4 Milestones
- •13.2 Introduction to Primary and Secondary Metabolites
- •13.2.1 Primary Metabolites
- •13.2.2 Roles and Significance
- •13.2.2.1 Primary Metabolites
- •13.2.2.2 Secondary Metabolites
- •13.3 General Metabolic/Synthetic Pathway Which Shows from CO2 to Different Primary and Secondary Metabolite Formation
- •13.4 Enzymes
- •13.4.1 Functions of Enzymes
- •13.4.2 Catalytic Mechanism
- •13.5 Role of Enzymes in Biosynthetic Pathways
- •13.5.1 Basic Metabolic Pathway and Their Utilization to Produce Secondary Metabolite
- •13.5.1.1 Basic Metabolic Pathways
- •13.5.1.2 Utilization for Secondary Metabolites
- •13.5.1.4 Keto-enol Tautomerism
- •13.6 Other Structural Modifications
- •13.6.1 Isomerization
- •13.6.2 Hydrogenation and Dehydrogenation
- •13.6.3 Ring-Opening and Ring-closing Reactions
- •13.6.4 Functional Group Inter-conversion
- •13.6.5 Modern Techniques in Structural Elucidation
- •13.6.6 Importance in Drug Design and Synthesis
- •13.6.7 Intermediates and End Products in Secondary Metabolic Pathways
- •13.6.8 Integration of Pathways
- •13.7 Shikimic Acid Pathway for Biosynthesis of Aromatic Amino Acids
- •13.10 Acetate Mevalonate Pathways for Biosynthesis of Fatty Acyl-CoA
- •References
- •14. Pharmaceutical Aids of Natural Origin
- •14.1 Introduction
- •14.2 Some Industrially Important Pharmaceutical Aids
- •14.2.1 Acacia Gum
- •14.2.2 Agar-agar
- •14.2.3 Albumin
- •14.2.4 Alginates
- •14.2.5 Anthocyanidins
- •14.2.6 Cellulose
- •14.2.7 Chitosan
- •14.2.8 Cochineal
- •14.2.9 Curcumin
- •14.2.10 Gelatin
- •14.2.11 Gellan Gum
- •14.2.12 Guar Gum
- •14.2.13 Gum Karaya
- •14.2.14 Gum Tragacanth
- •14.2.15 Inulin
- •14.2.16 Lawsone
- •14.2.17 Locust Bean Gum
- •14.2.18 Pectins
- •14.2.19 Starch
- •14.2.20 Tamarind Gum
- •14.2.21 Xanthan Gum
- •14.3 Conclusion
- •References
- •15. Nutraceuticals and Cosmeceuticals
- •15.1.1 Definition of Nutraceuticals and Cosmeceuticals
- •15.1.2 Historical Overview
- •15.1.3 Significance in Modern Healthcare and Beauty Industries
- •15.2 Nutraceuticals
- •15.2.1 Definition and Classification
- •15.2.1.1 Functional Foods
- •15.2.1.2 Dietary Supplements
- •15.2.2 Key Components and Ingredients
- •15.2.2.1 Vitamins and Minerals
- •15.2.2.2 Antioxidants
- •15.2.2.3 Omega-3 Fatty Acids
- •15.2.2.4 Probiotics
- •15.2.3 Health Benefits
- •15.2.3.1 Nutraceutical in Disease Prevention
- •15.2.3.2 Immune System Support
- •15.2.3.3 Cognitive Health
- •15.2.3.4 Anti-inflammatory Effects
- •15.3 Cosmeceuticals
- •15.3.1 Definition and Classification
- •15.3.1.1 Skin Cosmeceuticals
- •15.3.1.2 Creams Cosmeceuticals
- •15.3.1.3 Hair Cosmeceuticals
- •15.3.1.4 Antiaging Cosmeceuticals
- •15.3.2 Active Ingredients
- •15.3.2.1 Retinoid
- •15.3.2.2 Peptide
- •15.3.2.3 Hyaluronic Acid
- •15.3.2.4 α-Hydroxy Acids and β-Hydroxy Acids
- •15.3.3 Beauty and Dermatological Benefits
- •15.3.3.1 Wrinkle Reduction
- •15.3.3.2 Moisturization and Hydration
- •15.3.3.3 Sun Protection and Acne Management
- •15.4 Synergies Between Nutraceuticals and Cosmeceuticals
- •15.4.1 Nutraceutical and Cosmeceutical (Nutra-cosmetical)
- •15.4.2 Internal and External Approaches to Health and Beauty
- •15.4.3 Complementary Benefits
- •15.4.3.1 Skin Health from Within
- •15.4.3.2 Holistic Approaches to Beauty and Wellness
- •15.5 Regulatory Considerations
- •15.5.1 FDA Guidelines for Nutraceuticals
- •15.5.2 Cosmetic Regulations and Approvals
- •15.5.3 Challenges and Opportunities in Compliance
- •15.6 Future Trends and Innovations
- •15.6.1 Advances in Nutraceutical Research
- •15.6.2 Cutting-edge Cosmeceutical Technologies
- •15.6.3 Market Trends and Consumer Preferences
- •15.7 Conclusion
- •References
- •16. Pesticides and Allergens
- •16.1 Introduction
- •16.2 Natural Pesticide/Biopesticides and Natural Anti-allergens: Source, Bioactive Substances and Applications
- •16.2.1 Natural Pesticides/Biopesticides
- •16.2.1.1 Plant-based Biopesticides
- •16.2.1.2 Insect-based Biopesticides
- •16.2.1.3 Marine-based Biopesticides
- •16.2.1.4 Animal-based Biopesticides
- •16.2.1.5 Microorganism-based Biopesticides
- •16.2.2 Natural Anti-allergens
- •16.2.2.1 Plant-based Anti-allergens
- •16.2.2.2 Insect-based Anti-allergens
- •16.2.2.3 Marine-based Anti-allergens
- •16.2.2.4 Animal-based Anti-allergens
- •16.2.2.5 Microorganism-based Anti-allergens
- •16.3 Pharmacological Mechanism and Toxicity Profile of Some Common Natural Pesticides and Anti-allergens
- •16.3.1 Natural Pesticides or Biopesticides
- •16.3.1.1 Azadirachtin
- •16.3.1.2 Abamectin
- •16.3.1.3 Nicotine
- •16.3.1.4 Bacillus thuringiensis (Bt)
- •16.3.1.5 Ryania
- •16.3.1.6 Spinosad
- •16.3.1.7 Pyrethrins
- •16.3.1.8 Rotenone
- •16.3.2 Pharmacological Mechanism and Toxicity of Natural Anti-allergens
- •16.3.2.1 Tussilagone
- •16.3.2.2 Mangiferin
- •16.3.2.3 Shikonin
- •16.3.2.4 Okicamelliaside
- •16.4 Global Market Surveillance of Biopesticides and Anti-allergens
- •16.5 Commercial Production and Formulations of Natural Pesticides and Anti-allergens
- •16.5.1 Commercial Production of Natural Pesticides
- •16.6 Regulatory Aspects for Quality Control of Pesticides and Anti-allergens
- •16.6.1 Regulatory Standard for Pesticides
- •16.6.2 The Regulatory Standard for Anti-allergens
- •16.7 Future Prospects and Opportunities
- •Acknowledgments
- •Conflict of Interest
- •Funding
- •References
- •17. Comparative Phytochemistry and Chemotaxonomy
- •17.1 Introduction
- •17.2 Chemotaxonomy
- •17.3 Chemical Markers in Chemotaxonomy
- •17.3.1 Primary Metabolites
- •17.3.2 Secondary Metabolites
- •17.3.2.1 Glycosides
- •17.3.2.2 Alkaloids
- •17.3.2.3 Terpenoids
- •17.3.2.4 Phenolic Compounds
- •17.4 Methods in Chemotaxonomy
- •17.4.1 Chromatography
- •17.4.2 Spectroscopy
- •17.5 Phytochemical Approach in Chemotaxonomy
- •17.5.1 Fatty Acids
- •17.5.2 Alkaloids
- •17.5.3 Phenolic Compounds
- •17.5.4 Essential Oils
- •17.5.5 Glycosides
- •17.5.6 Lignans
- •17.6 Limitations of Chemotaxonomy
- •17.7 Conclusion
- •References
- •18. Medicinal Plant Biotechnology
- •18.1 Introduction
- •18.2 Plant Tissue Culture
- •18.2.1 History of Plant Cell Culture Technology
- •18.2.2 Nutritional Requirements and Cultural Media
- •18.2.3 Plant Tissue Culture Laboratory Requirements
- •18.2.4 Micropropagation
- •18.2.5 Types of Culture
- •18.2.6 Synthetic Seed or Artificial Seed
- •18.2.7 In-Vitro Plant Germplasm Conservation
- •18.2.8 Plant Cell Immobilization
- •18.2.8.1 Methods of Immobilization
- •18.2.9 Biotransformation
- •18.2.10 Applications of Plant Tissue Culture
- •18.3 Genetic Engineering (Recombinant DNA Technology)
- •18.3.1 Restriction Endonuclease
- •18.3.2 Vectors as Carriers of Transgene
- •18.3.3 Methods of Gene Transfer
- •18.3.3.1 Direct Gene Transfer Methods
- •18.3.3.2 Indirect Gene Transfer Methods
- •18.3.4 Applications of Genetic Engineering
- •18.4 Conclusion
- •References
- •19. Marine Pharmacognosy
- •19.1 Introduction
- •19.1.1 Exploring Marine Organisms for Bioactive Compounds
- •19.1.2 Importance of Marine Organism in Drug Discovery
- •19.2 Marine Ecosystems and Biodiversity
- •19.2.1 Types of Marine Ecosystems
- •19.2.2 Biodiversity in Marine Environments
- •19.2.3 Adaptations and Survival Strategies
- •19.2.4 Ecosystem Services Provided by Marine Biodiversity
- •19.2.5 Biodiversity Threats and Conservation
- •19.3 Bioactive Compounds from Marine Microorganisms
- •19.3.1 Microbial Diversity in the Marine Environment
- •19.3.2 Isolation and Characterization Techniques
- •19.3.3 Pharmaceutical Applications
- •19.4 Marine Algae and Their Medicinal Potential
- •19.4.1 Diversity of Marine Macroalgae
- •19.4.1.1 Cyanobacteria as Marine Microalgae
- •19.4.1.2 Marine Macroalgae
- •19.4.2 Bioactive Compounds and Their Applications
- •19.4.2.1 Pigments
- •19.4.2.1.1 Polyunsaturated Fatty Acids
- •19.4.2.2 Proteins
- •19.5 Marine Invertebrates and Its Bioactive
- •19.5.1 Sponges (Phylum Porifera)
- •19.5.2 Molluscs
- •19.5.3 Echinoderms
- •19.6 Extraction Process and Characterization Techniques
- •19.6.1 Collecting and Processing of Marine Compounds
- •19.6.2.1 Supercritical Water Extraction
- •19.6.2.2 Supercritical Fluid Extraction
- •19.6.2.3 Solid-phase Extraction
- •19.6.2.4 Microwave-assisted Extraction
- •19.6.3 Analytical Tools and Technologies
- •19.6.3.1 Biological Screening
- •19.6.3.2 Thin-layer Chromatography Analysis
- •19.6.3.3 Nuclear Magnetic Resonance Analysis
- •19.6.3.4 Mass Spectroscopy
- •19.7 Pharmacological Activities of Marine-derived Compounds
- •19.7.1 Anticancer Properties of Marine Compounds
- •19.7.1.1 Marine Plants
- •19.7.1.1.1 Macroalgae (Seaweed)
- •19.7.1.1.2 Microalgae
- •19.7.1.2 Marine Fungi
- •19.7.1.3 Marine Bacteria
- •19.7.1.4 Softcorals
- •19.7.2 Neuroprotective and Neuropharmacological Effects
- •19.7.2.1 Parkinson’s Disease
- •19.7.2.1.1 Fucoidan
- •19.7.2.1.2 Seaweeds
- •19.7.2.1.3 Astaxanthin
- •19.7.2.2 Alzheimer’s Disease
- •19.7.2.2.1 Hymenialdisine
- •19.7.2.2.2 Cerebrosides
- •19.8 Preclinical and Clinical Studies of Marine Microorganisms
- •19.8.1 Aplidin (Plitidepsin)
- •19.8.2 Bryostatin-1
- •19.8.3 Dolastatin 10 (IMMU-110)
- •19.8.4 Halaven (Eribulin)
- •19.8.5 Squalamine
- •19.8.6 Lurbinectedin
- •19.9 Marketed Marine Drug Product
- •19.10 Future Prospects
- •19.10.1 Advancements in Marine Natural Product Research
- •19.10.2 Overcoming Challenges in Sustainable Marine Development
- •19.11 Conclusion
- •References
- •20. Molecular Pharmacognosy
- •20.1 Introduction
- •20.1.1 History and Evolution of Pharmacognosy
- •20.1.2 Current Trends in Pharmacognosy
- •20.1.3 Scope and Objectives
- •20.2 Molecular Biology Techniques in Pharmacognosy
- •20.2.1 DNA Extraction, Polymerase Chain Reaction, Sequencing, and Cloning
- •20.2.2 Significance of Different Molecular Biology Techniques
- •20.3 Molecular Genetics and Genomics of Medicinal Plants
- •20.3.1 Genomics of Medicinal Plants
- •20.3.1.1 Genome Evolution
- •20.3.1.2 Genome Duplication
- •20.3.1.3 Examining the Molecular Genetic Basis for the Economic Features of Medicinal Herbs Using Whole Genome Sequences
- •20.3.1.4 Transcriptome Analysis
- •20.3.1.5 Case Studies of Herbal Genomics
- •20.3.2 Genetics
- •20.3.2.1 Novel Technologies in Genetics and Biotechnology to Evaluate Genetic Multiplicity and Analyze Genomic and Transcriptomic Data
- •20.4 PTC of Medicinal Plants
- •20.4.1 Direct Applications of PTC
- •20.4.1.1 Mass Propagation
- •20.4.1.2 Germplasm Conservation
- •20.4.1.3 Secondary Metabolite Production
- •20.4.1.4 Genetic Improvement
- •20.4.1.5 Accelerated Breeding Programs
- •20.4.2 Indirect Applications of Plant Tissue Culture
- •20.4.2.1 Ploidy Engineering
- •20.5 Molecular Biosynthesis and Metabolomics of Medicinal Plants
- •20.5.1 Importance and Application of Metabolomics in Medicinal Plant Research
- •20.5.2 Metabolomics Techniques and Analytical Tools
- •20.6 Molecular Pharmacology and Toxicology of Medicinal Plants
- •20.6.1 Pharmacology of Medicinal Plants
- •20.6.1.1 Phytochemical Analysis
- •20.6.1.2 Bioassays
- •20.6.1.3 Receptor Binding Studies
- •20.6.1.4 Pharmacodynamics, Pharmacokinetics, and Clinical Trials
- •20.6.2 Toxicology of Medicinal Plants
- •20.6.2.1 In Vivo Toxicity Studies
- •20.6.2.2 In Vitro Toxicity Assays
- •20.6.2.3 Safety Pharmacological Studies
- •20.6.2.4 Risk Assessment
- •20.7 Mechanism of Action, Efficacy, and Toxicity of Plant-derived Drugs
- •20.8 Conclusion and Future Prospects
- •References
- •21. Clinical Pharmacognosy
- •21.1 Introduction
- •21.2 Pharmacognosy
- •21.2.1 Emerging Areas in Pharmacognosy
- •21.2.1.1 Forensic Pharmacognosy
- •21.2.1.2 Molecular Pharmacognosy
- •21.2.1.3 Ecopharmacognosy
- •21.2.2 Function of Pharmacognosy in Healthcare System
- •21.3 Clinical Pharmacognosy
- •21.3.1 Role of Clinical Pharmacognosy in Healthcare System
- •21.3.2 Drug Interaction Studies on Botanicals and Dietary Supplements
- •21.3.2.1 Concept of Drug Interaction
- •21.3.2.1.1 Risk Factors for Drug Interactions
- •21.3.2.1.2 Effect of Dietary Supplements and Botanicals on Drug
- •21.3.2.1.3 Effect of Drugs on Dietary Supplements and Botanicals
- •21.3.2.2 Drug Interaction with Botanicals and Dietary Supplements
- •21.3.2.2.1 Examples of Drug Interaction with Botanicals and Dietary Supplements
- •21.3.3.1 Natural Allergenic Extracts: Production and Quality Control
- •21.3.3.2 Methods for the Quality Control of Allergenic Extracts with their Advantages and Disadvantages
- •21.3.3.3 Allergenic Extracts for Diagnosis and Treatment (Table 21.3)
- •21.4 Clinical Studies on Botanicals and Dietary Supplements
- •21.4.1 Phase I, II, III, and IV Trial on Botanicals, and Dietary Supplements with Example
- •21.5 Clinical Pharmacokinetics
- •21.5.1 Clinical Support of the Herbal-drug Interaction Caused by the Blockage of Transporters and Drug-metabolizing Enzymes
- •21.5.1.1 Hydrastis Canadensis
- •21.5.1.2 Kava Kava
- •21.6 Phytoequivalence
- •21.7 Future Prospects of Clinical Pharmacognosy
- •21.8 Conclusion
- •References
- •Index

5.5 Good Collection Practices for Medicinal Plants 91
Table 5.3 Examples of plant parts and harvesting timing.
Sr. No Plant part Time of collection Examples
1 Seed After maturity, washed and freed from pulp Nux Vomica, Cocoa.
2 Fruit Ripe, half ripe or fully mature Coriander, Dill, Bael.
3 Resin Immediately after oozing from plant, in dry weather Balsam of Peru, Balsum of Tolu.
4 Gum After oozing, when it dries or hardens, in dry weather Acacia, Tragacanth
5 Latex After oozing out, after coagulation Papaya, Opium.
6 Heartwood After maturation Sandal wood.
7 Pod After maturation Senna
During the harvest phase, meticulous attention must be
devoted to preventing the incorporation of foreign organic
and inorganic matter, weeds, or poisonous plants into the
harvested medicinal herbs. The harvesting of medicinal
plants should be executed in optimal conditions, with a
deliberate avoidance of dew, rainfall, or excessively high
dampness. Maintenance of cutting devices, harvesters, and
other machinery necessitates keeping them in a clean and
uncontaminated condition. These tools should be stored in
a dry facility that is devoid of insects, rodents, birds, and
other pests. Additionally, the storage area should be
inaccessible to livestock and domestic animals. Direct
interaction between harvested plants and soil should be
averted to prevent contamination.
When harvesting medicinal plants that utilize under
ground parts like roots, it is essential to promptly remove
any adhering soil from the plant materials. During transportation to the processing unit, it is crucial to expedite the
process using clean containers and ensuring dry conditions. Special attention should be given to preventing
physical damage or compaction of the raw materials of
medicinal herbs. Such issues may arise, for example, due
to excessive filling or the stacking of sacks or bags, poten
tially leading to composting or a reduction in quality.
Identifying and discarding decaying medicinal herbal
materials during harvest, post-harvest scrutiny, and processing is imperative to mitigate the consequence of
microbial contamination and the subsequent deterioration of product property.
5.5 Good Collection Practices for Medicinal Plants
This segment outlines comprehensive approaches and fundamental processes for the small- and large-scale gathering
of fresh medicinal herbs. The primary emphasis is on
methodologies designed to ensure the prolonged viability
of natural populations and their associated ecosystems.
Plans for the management of collection must explain sustainable harvesting thresholds and specify suitable methods tailored to each medicinal plant species and the specific
plant component under consideration, whether it be roots,
leaves, fruits, and so forth [8].
5.5.1 Collection Permissions
In certain nations, it is essential to secure collection permits and other official documentation from governmental
bodies and landowners before gathering plants from their
natural habitats. It is advisable to refer to and comply with
national legislation, including the examination and adher
ence to national “red” listed plants. In order to export
medicinal plant materials from the nation of origin, it is
imperative to obtain several essential documents. These
include export permits, phytosanitary certificates, permits
from the Convention on International Trade in Endangered
Species of Wild Fauna and Flora (CITES) for both export
and import, re-export certificates for CITES, and any addi
tional permits mandated by the relevant authorities.
5.5.2 Technical Planning
-
Prior to commencing the collection process, it is essential to
assess the geographic dissemination and population intensity of the targeted medicinal plant species. Consideration
should include the closeness of the field from the home base
and the quality of available target plants. Crucial details
about the targeted species, including taxonomy, distribution,
phenology, genetic diversity, reproductive biology, and eth
nobotany, must be collected. Additionally, data pertaining to
the topography, geology, soils, climate, vegetation, and other
environmental conditions of potential collection sites should
be compiled and incorporated into the collection plan.
Botanical notes and other taxonomic recognition aids prove
valuable at collection sites, especially when encountering
related or unrelated species with similar morphological
appearances. It is also beneficial to have photograph copies
-
-
-

92 5 Cultivation, Collection, and Preparation of Plant Drugs
and other images of the targeted medicinal herb sourced
from standard books and herbarium, as well as ethnographic
information such as common or local names of the target
species and plant parts. These resources are particularly useful in the field, specifically for inexperienced workers.
Furthermore, comprehensive training is essential for collection teams to ensure proficiency in appropriate collection
techniques. These teams hold the responsibility of conserving and managing the desired medicinal plant species in
their natural habitat.
5.5.3 Social and Ecological Impact
Examining the impact of field collection on local communities is essential, and there is a continuous need for monitoring the ecological consequences. Ensuring the resilience
of the natural habitat and maintaining viable populations
of the targeted species within the collection region remains
of utmost significance. This critical analysis delves into the
repercussions of field collection, emphasizing the ongoing
importance of ecological monitoring and the preservation
of the natural habitat to sustain the populations of the species being targeted.
To ensure the best results, various methods are employed
to process each individual herb. The processing of plantbased ingredients involves multiple stages that the raw
drug undergoes after harvest. These stages can be categorized into primary processing and secondary processing
and can be further classified as mentioned below [9, 10]:
Primary processing: it is simple processing used for sort-
ing of herbal drugs using the following process:
1. Garbling
2. Washing
3. Parboiling
4. Leaching
5. Drying
Secondary processing: this process includes refining and
purifying plant materials. It enhances the value of the raw
plant material and ensures that the final product meets
quality, safety, and effectiveness standards.
1. Cutting/sectioning
2. Aging/sweating
3. Baking/roasting
4. Boiling/steaming
5. Stir frying etc.
5.5.4 Selection of Medicinal Plants for Collection
While selecting the specific plant species or botanical varieties for collection, it is advisable to adhere to the guidelines outlined in the national pharmacopoeia or those
recommended by reputable national authorities within
the user’s country. In the case of newly introduced medicinal plants, it is essential to identify and document the chosen species or botanical variety by referencing the source
material used or described in traditional medicine from
their native regions. For individuals engaged in collecting
or producing medicinal plant materials and herbal medicines, it is strongly recommended to create botanical specimens and submit them to regional or national herbaria
for authentication. It is suggested to retain voucher specimens for a suitable duration under appropriate conditions
and record the taxonomist name or other authorities who
provided the botanical authentication. In case the medicinal plant is unfamiliar to the community, document and
maintain records of its botanical identity.
5.6 Processing of Medicinal Plants
The complete transformation of raw materials, starting
from their initial state in the field and culminating in the
final product, constitutes the processing of medicinal
plants. This complex process comprises a series of steps
that vary depending on the unique properties of each herb.
5.6.1 Primary Processing
Garbling: It is crucial for maintaining quality standards in
the herbal industry. It involves the systematic sorting and
selection of dried plant material to eliminate impurities,
foreign matter, or undesired plant parts, ensuring the
purity and quality of the final product. The process includes
removing extraneous materials like twigs, stones, or contaminants to meet regulatory requirements and consumer
expectations. Garbling employs procedures such as visual
inspection, sieving, and sometimes mechanical equipment
to achieve standardized and pure herbal material [11].
Washing: It is the essential step following garbling, helping to clean the raw material and remove any remnants of
soil, dirt, and additional impurities present on the surface.
Parboiling: The parboiling process, consisting of immersing certain herbal raw materials in boiling water, brings
about several advantages. This procedure serves a dual
function, ensuring the preservation of the raw material by
preventing insect infestation and fungal contamination, as
well as playing a vital role in subsequent processing by aiding in the elimination of persistent impurities and outer
coatings from the raw materials. Through this dual-function process, the overall cleanliness and readiness of the
material for subsequent stages in the processing chain are
enhanced.
Leaching: Leaching is a process where some impurities
are eliminated by exposing the plant material to flowing
water. Nevertheless, it is crucial to regulate the leaching

5.7 Storage and Packaging 93
duration to avoid the depletion of the chemical constituents inherent in the medicinal plant. This step is crucial in
ensuring that impurities are effectively removed while preserving the valuable components of the plant material.
Drying: The drying of plant material is an essential stage
in the preparation of herbal products. After the raw plant
material has been harvested, cleaned, and possibly subjected to additional initial processing stages, it is essential
to remove excess moisture to improve its stability and
prevent microbial growth. Air-drying, sun-drying, ovendrying, and freeze-drying are among the most common
techniques for dehydrating plant materials. The selection
of a drying method is frequently influenced by variables
such as the type of plant material, the local climate, and the
intended qualities of the final product.
Proper drying is required to prevent the decomposition
of active constituents and preserve the botanical material’s
overall quality. During the dehydrating process, excessive
heat must be avoided to prevent the loss of volatile compounds and other bioactive components. Additionally, drying time is a crucial factor to consider. It must be long
enough to accomplish the desired moisture content for
storage and subsequent processing, but not so long as to
compromise the therapeutic properties of the plant.
5.6.2 Secondary Processing
Secondary processing varies among different herbs, contingent upon the specific nature of active ingredients and
therapeutic properties inherent in each. This stage encompasses various techniques, including the elimination of
foreign materials, microbial infestation prevention, augmentation of drug effectiveness, mitigation of toxicity, and
extraction utilizing appropriate solvents. Additionally, it
encompasses procedures, such as concentrate formation
and the drying of extracts.
5.6.2.1 Cutting/sectioning
After drying, herbal materials are chopped and sectioned
for storage and extraction. The preparation of either a
coarse or fine powder is determined by the specific portion
of the plant and the extraction techniques applied.
5.6.2.2 Aging/sweating
The aging process involves preserving raw materials after
harvesting for a predetermined duration, typically up to a
year, either in the sun or in the shade. During this period,
excessive water evaporates, and enzymatic reactions might
transpire, inducing alterations in the chemical composition of the herbal material. To illustrate, cascara bark
requires aging for a minimum of one year before incorporation into therapeutic formulations to alleviate its potential irritant effects.
The process of sweating involves exposing herbal materials to elevated temperatures ranging from 45 to 65°C, coupled with high moisture, for a duration spanning from a
week to several months. In this phase, plant materials are
thoughtfully layered between blankets (woolen or alternative types of fabric). The aging process is recognized as a
hydrolytic and oxidative mechanism, wherein certain
chemical constituents within the herbs undergo hydrolysis
or oxidation. For instance, vanilla beans undergo a sweating
process, confined between woolen blankets, lasting approximately two months. Throughout this period, the beans
experience a weight loss of up to 80%, concurrently acquiring a distinctive and desirable color and aroma.
5.6.2.3 Baking/roasting
It involves subjecting herbal material to a heating process
in ovens, with the temperature and duration of baking or
roasting varying according to the specific herbal material.
This is continued until the drug attains a distinct coloration; for instance, nutmeg and tobacco leaves are roasted
until they achieve a yellowish-brown hue.
5.6.2.4 Boiling/steaming
In the boiling procedure, the medicinal substance undergoes immersion in a liquid solvent like water, vinegar,
wine, milk, or even animal urine. As an example, the rhizome of Acorus calamus is boiled in cow’s urine to enhance
its anticonvulsant properties.
The steaming method involves subjecting herbal components to steam through a steamer, resulting in the creation
of a moist texture. As an example, Polygonum multiflorum
roots undergo steaming in the presence of a decoction
made from black beans to enhance their tonic effects.
5.6.2.5 Stir-frying
During this method, plant materials are kept in a vessel
or frying pan and heated. They are then stirred or tossed
over and over for a certain amount of time, until the outside color changes, which can range from charring to
carbonization. The medicine may be mixed with things
like sand, talc, or clay to make sure it heats evenly. For
example, honey can be added to the stir-frying of liquorice stems and rhizomes.
5.7 Storage and Packaging
Proper storage facilities for medicinal materials necessitate
well-ventilated, dry environments shielded from light.
When deemed necessary, these facilities should be
equipped with air-conditioning and humidity control systems, along with measures to safeguard against rodents
and insects. The flooring should be neat, devoid of cracks,

94 5 Cultivation, Collection, and Preparation of Plant Drugs
and easy to maintain cleanliness. Storage on shelves is
recommended, ensuring an adequate distance between
the medicinal materials and the walls, while proactive
measures should be implemented to prevent potential
pest infestations.
It is advisable to store dried medicinal crude drugs, herbs,
and volatile oils in a facility that is both dry and wellventilated. This ensures stability by minimizing daily
temperature fluctuations and facilitating proper aeration.
On the other hand, fresh medicinal herbs should be stored
at optimal low temperatures, preferably between 2–8°C,
whereas frozen products require storage at temperatures
lower than –20°C.
Medicinal plant materials that have undergone processing
must be appropriately packaged using clean, dry containers,
such as boxes, sacks, or bags. This should be done in
accordance with established standard operating procedures
and must comply with the regulations set forth by both the
producing entity and the relevant national or regional
authorities in the end-user countries.
Packaging materials must adhere to stringent criteria to
ensure the integrity of medicinal plant materials. They
should be non-polluting, clean, dry, and free from any
damage, meeting the specified quality standards for
the respective medicinal plants. For delicate medicinal
plant materials, it is recommended to utilize rigid containers
5.8 Sample Record for Cultivated Medicinal Plants
Sample records for cultivated medicinal plants are crucial
for understanding their chemical composition, biological
activities, and potential therapeutic uses. These records,
gathered from sources like scientific literature, databases,
and experimental studies, should include details such as
the presence of essential oils, terpenoids, flavonoids, and
other secondary metabolites. Techniques like GC-MS,
HPLC, and NMR spectroscopy help analyze this chemical
composition. Additionally, these records should document the plant’s biological activities, like antioxidant,
antimicrobial, anti-inflammatory, and wound-healing
properties, which can be assessed through both lab experiments and traditional knowledge. It’s also important to
consider geographical variations, influenced by factors
like temperature and humidity, which affect the plant’s
composition and activities. Quality control measures,
including species identification, sample collection, storage, and analysis, ensure accuracy. Ultimately, these
records help uncover the potential medicinal uses of
plants, aiding in drug development and therapeutic agent
discovery [8].
Identification of cultivated medicinal plants follows
WHO GACP guidelines [8], ensuring accurate species recognition and adherence to quality standards for cultivation. Compliance with GACP guidelines ensures the
integrity and efficacy of cultivated medicinal plants for
therapeutic use. This process involves rigorous botanical
verification, including morphological and genetic identification, to guarantee plant authenticity and potency. GACP
guidelines also emphasize proper documentation of plant
sources, growth conditions, and harvesting techniques to
maintain consistency and traceability in medicinal plant
cultivation, as given below and in Table 5.4.
Additional remarks and suggestions: If necessary, document supplementary information or specific observations
on a separate sheet of paper.
Table 5.4 An overview of the growing conditions for plants. Year __________
Jan Feb Mar Apr May June Jul Aug Sept Oct Nov Dec
Sunlight duration (in hours)
Daytime average
temperature (oC)
Average temperature at
o
night (
C)
Normal rain (mm)
Plant growth (cm.)
Plant thickness (cm)
Condition of flower buds
Calyx structure
Pest destruction
Type of disease
Herbicide used

5.8 Sample Record for Cultivated Medicinal Plants 95
Jan Feb Mar Apr May June Jul Aug Sept Oct Nov Dec
Pesticide used
Branching density
Digging
Type of irrigation
Temperature
Speed of air
Drought
Plant part yield per plant
Record of cultivated medicinal herbs
Botanical name (identification up to species): ____________________________________
Regional name: _____________________________________________________________
English/ Commercial name (if available) _________________________________________
Part of plant to be collection: ________________________________________________
Harvest code no. (if any): ____________________________________________________
Record of geographical site utilized for cultivation of medicinal herbs
Location of cultivation site: _______________________________________________
Zone/State/Nation: ______________________________________________________
Record of grower
Growers Name: ___________________________________________________________
Communication details: _______________________________________________________
Propagation date: _________________________________________
Harvesting date: ___________________________________________
Record of propagation materials
Source of propagating material: _________________________________________________
Description of the of propagating material: ________________________________________
Available in mercantile market (circle): yes / no
If available, Breed name: ______________________ Traders name: ___________________
Record of cultivation
Method of propagation materials establishment (circle): direct seed sowing / transplants
First propagation date: _____________________________ Percentage success:__________________________________
Re-propagation date:_______________________________ Percentage success:__________________________________
Distance between rows (cm):________________________ Distance between plants (cm):_________________________
Size of planted area (m2):___________________________ Number of plants per unit area:________________________

96 5 Cultivation, Collection, and Preparation of Plant Drugs
Crop rotation followed:
Soil type: Percent clay _________________ Percent sand _________________ Percent silt _________________
Percent organic staple ____________________________ % Others (if any) __________________________
Soil pH__________________________________________ Soil fertility:good / poor
Retention of moisture in soil: good / poor______________ Effluence of Soil: good / poor
Artificial irrigation facility: yes / no___________________ Land (circle): plain / inclined
Irrigation type: Inudate / channel / sprinkler / drip
Water source: Tap water/pond/ river/ well / any other, Specify: _______
Water quality: Good / bad
Explanation:
Salinity of water (circle): Low / high
Name of neighboring plants:
Insects on adjoining plants (if any): Aphids/caterpillars/locust/other if any, specify:_____
Agrochemicals
Fertilizer applied before propagation: Farmyard manure / chemical
Name:_________________________________________ Technique
Time/date (dd/mm/yyyy):_________________________ Quantity used
Herbicides applied before propagation:
Name:_________________________________________ Technique
Time/date (dd/mm/yyyy):_________________________ Quantity used
Herbicides used after propagation
Name:_________________________________________ Technique
Time/date (dd/mm/yyyy): _________________________ Quantity used
Pesticides used:
Name:_________________________________________ Technique
Time/date (d/m/y):______________________________ Quantity used
Harvest/Collection
Collection date: _________________________________ Time of day:
Plant and environmental conditions:________________ Technique:
Crop yield:
Atypical events that could impact quality
(Adverse climatic conditions, encounters with toxic substances, infestations of pests, etc.):

5.9 Voluntary Certification Scheme for Medicinal Plant Produce in Indian Scenario 97
5.9 Voluntary Certification Scheme for Medicinal Plant Produce in Indian Scenario
The Voluntary Certification Scheme for Medicinal Plant
Produce (VCSMPP) is a certificate that ensures fairness for
evaluation and certification of medicinal herbs. The objective of this practice is to ensure that individuals engaged in
cultivating plants on agricultural lands or harvesting them
from natural habitats adhere to specific regulations and
maintain a consistent approach. The certification process
defines the requisite documentation necessary for the issuance of certificates related to medicinal plants. The
National Medicinal Plant Board (NMPB), in collaboration
with the Quality Council of India (QCI), issues a certificate
based on two sets of good practices: GAP for plants grown
on farms and Good Field Collection Practices (GFCP) for
those collected from the wild, even if they go through a
middleman like a trader. The scheme would benefit everyone involved in the production and use of herbs, including
cultivators, traders, users, and consumers. It would ensure
a supply of high-quality raw materials for the AYUSH
industry, which would lead to better-quality herbal products for consumers. There are four different ways that people who grow, collect, or trade medicinal plants can get
certified.
a) A producer or collector requests for certification on an
individual basis and receives it for their produce.
b) A producer/collector collective asks for certification as
a group, and the group is granted certification as a
legal entity.
c) The individual farmer might choose the lot-wise certi-
fication model based on GAP, in which case he or she
obtains a certificate of compliance for a quantity of
produce that is submitted for inspection to an authorized certifying authority.
d) A middleman, such as a trader, requests certification
of the certified medicinal plant production to be used
as a supply in the market or as a manufacturer or processor of AYUSH products.
5.9.1 Certification Process: For individual farmer/collector
The prospective applicant shall apply to the Certification
Bodies (CBs) on the application form prescribed and provide the minimum information on:
a. The name and address of the applicant along with con-
tact details
b. Proof of legal entity
c. Location and total land held at location
d. Whether land is held under ownership or lease
e. Produce being handled
f. Relevant certification criteria GAP/GFCP under which
certification is sought
g. Produce a handling area
h. Number and competence of manpower
i. Annual area under cultivation/collection
j. Covered medicinal produces area-wise within the
annual area
k. Since when the area is under the medicinal plants
l. Any registration with government department (like
State Medicinal Plant Board, etc.)
• CBs will analyze the application to ensure it is
adequate, and any flaws found will be notified to
the applicant within the allotted period after the
application is received.
• For both internal and external evaluation, control
criteria and a compliance checklist based on the
relevant standards shall be employed. Preassessment is optional but is recommended.
• Within three months of registering an application, an
initial assessment of the applicant’s products and
processes at their site must be carried out; harvest
time is the best time to do this evaluation.
• A representative produce shall be taken for testing in a
separate laboratory for testing against contaminants
(heavy metals, aflatoxins, and pesticide residues) and
TLC profiling for species if needed. The maximum
allowed limits are given in Table 5.5.
• All three of the GAP/GFCP standard’s compliance
criteria – critical, major, and minor – must be met by a
grower. The requirements for plants included in the
Ayurvedic Pharmacopoeia of India (API),
Homoeopathic Pharmacopoeia of India (HPI), Unani
Pharmacopoeia of India (UPI), and other pertinent
standard official texts are in addition to these needs.
▪
The following criteria will be used to determine the
compliance level:
a. Critical – All applicable critical control points
must be completely in compliance.
b. Major – All major control points must be observed to
be in 90% compliance.
c. Minor – All relevant minor control points must be
at least 75% compliant.
d. The product should be in compliance with major
contaminants.
e. TLC profile analysis, if required.
f. If necessary, testing in accordance with API/HPI,
etc.

98 5 Cultivation, Collection, and Preparation of Plant Drugs
Table 5.5 Permissible Levels of Contaminants Under GAP And GFCP.
Heavy metals
Sr. No Parameters Permissible limits
1 Lead (Pb) 10 ppm
2 Cadmium (Cd) 0.3 ppm
3 Arsenic (As) 3 ppm
4 Mercury (Hg) 1 ppm
Aflatoxins
5 B1 0.5 ppm
6 G1 0.5 ppm
7 B2 0.1 ppm
8 G2 0.1 ppm
Microbial contamination
10 Salmonella sp./g Absent
11 Pseudomonas aeruginosa/g Absent
12 E. coli/g Absent
13 Total microbial plate count (TPC) 10
5
14 Total yeast and moulds 103/g
/g
Pesticide Residue
Substance Limit (mg/kg)
Alachlor 0.02
Aldrin and Dieldrin (sum of) 0.05
Azinphos-methyl 1.0
Bromopropylate 3.0
Chlordane (sum of cis-, trans - and Oxythlordane) 0.05
Chlorfenvinphos 0.5
Chlorpyrifos 0.2
Chlorpyrifos-methyl 0.1
Cypermethrin (and isomers) 1.0
DDT (sum of p, p-’DDT, o, p-’DDT, p, p-’DDE and p,p-’TDE 1.0
Deltamethrin 0.5
Dichlorvos 1.0
Dithiocarbamates (as CS2) 2.0
Endosulfan (sum of isomers and Endosulfan sulphate) 3.0
Endrin 0.05
Ethion 2.0
Fenitrothion 0.5
Fenvalerate 1.5

Fonofos 0.05
Heptachlor (sum of Heptachlor and Heptachlorepoxide) 0.05
Hexachlorobenzene 0.1
Hexachlorocyclohexane isomers (other than γ) 0.3
Lindane (γ-Hexachlorocyclohexane) 0.6
Malathion 1.0
Methidathion 0.2
Parathion 0.5
Parathion-methyl 0.2
Permethrin 1.0
Phosalone 0.1
Piperonyl butoxide 3.0
Pirimiphos-methyl 4.0
Pyrethrins (sum of) 3.0
Quintozene (sum of quintozene, pentachloroaniline and methyl
pentachlorophenyl sulphide)
1.0
References 99
• Upon compliance of all standards and satisfactory
resolution of critical control points, which are categorized as critical, major, and minor, CBs shall grant
certificates.
• The certified sites will have their surveillance evalu-
ated at least once a year, with a maximum of one year
between inspections. The raw material samples of
approved traders must be purchased from the marketplace or obtained from buyers. They then need to be
examined in independent labs to make sure they meet
the certification criteria. Fifty percent samples should
be from market (Website: https://nabcb.qci.org.in/
pcb/). [12]
In order to apply for group certification, it is necessary to
have a producer/collector group, which must be a legally
recognized business. Individual farmers can choose the lotwise certification model based on GAP, wherein they obtain
a certificate of conformity for the produce lot they submit to
the approved certification body for inspection. In an alternative approach, an intermediary entity, like a trader, has the
option to seek certification for the approved medicinal plant
yield. This certification is sought for the proper storage of the
produce, either for market distribution or for supplying to
manufacturers/processors engaged in the production of
AYUSH products. The information is available on the website of the Quality Council of India. (https://qcin.org/ckdocs/1586972217.6.%20Certification%20Process_
version%20II_Sep_2017.pdf)
References
1 Abdel-Aziz, S. M., Aeron, A. and Kahil, T. A. (2016).
Health Benefits and Possible Risks of Herbal Medicine.
In: Garg N, Abdel-Aziz SM, Aeron A, editors. Microbes
in Food and Health, 97–116. Cham: Springer
International Publishing.
2 Fathi, H., Ebrahimzadeh, M.A., Ataie, R. et al. (2020).
The importance of using medicinal plants and natural
products in order to treat depression, regarding iranian
traditional and islamic medicine and laboratory studies.
Tabari Biomedical Student Research Journal, 20 (3):
38–47.
3 Patil, D. and Patil, M. (2010). Diversity and concerns
of indian medicinal plants: a scenario. Journal of
Ecobiotechnology, 2 (8): 14–20.
4 Singh, A. and Sengar, R. (2017). Medicinal plants:
Treasure trove for future. Agricultural Research &
Technology: Open Access Journal, 9 (1): 555753.
5 Namdeo, A.G. (2018). Cultivation of medicinal and
aromatic plants. In: Natural Products and Drug
Discovery, 525–53. Elsevier.
6 Kokate, C., Purohit A., and Gokhale, D.S. (2008).
Pharmacognosy: Nirali prakashanPune, India.
7 Anonymous. (2009). Good Agricultural Practices for
Medicinal Plants. National Medicinal Plant Board
Department of AYUSH Ministry of Health and Family
Welfare, Government of India In collaboration with

100 5 Cultivation, Collection, and Preparation of Plant Drugs
World Health Organization (WHO). Sun Offset,
New Delhi India.
8 Anonymous. (2003). WHO Guidelines on good
agricultural and collection practices [GACP] for
medicinal plants: World Health Organization.
9 Hornok, L. (1992). Cultivation And Processing of
Medicinal Plants. John Wiley & Sons Ltd. Chichester.
181–92.
10 Porwal, O., Singh, S.K., Patel, D.K. et al. (2020).
Cultivation, collection and processing of medicinal
plants. Bioactive Phytochemicals: Drug Discovery to
Product Development, 17: 14–30.
11 Alamgir, A. and Alamgir, A. (2017). Herbal drugs: their
collection, preservation, and preparation; evaluation,
quality control, and standardization of herbal drugs.
Therapeutic Use of Medicinal Plants and Their Extracts
Pharmacognosy, 1: 453–95.
12 NABCB. Voluntary Certification Scheme for Medicinal
Plant Produce. India: National Accreditation Board for
Certification Bodies.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
